AU2002213804A1 - Material for producing products having fibrinolytic and/or antibacterial properties - Google Patents

Material for producing products having fibrinolytic and/or antibacterial properties

Info

Publication number
AU2002213804A1
AU2002213804A1 AU2002213804A AU1380402A AU2002213804A1 AU 2002213804 A1 AU2002213804 A1 AU 2002213804A1 AU 2002213804 A AU2002213804 A AU 2002213804A AU 1380402 A AU1380402 A AU 1380402A AU 2002213804 A1 AU2002213804 A1 AU 2002213804A1
Authority
AU
Australia
Prior art keywords
active substance
molecular sieve
fibrinolytic
water
crystallization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213804A
Inventor
Michael Bruder
Konrad Giessmann
Karl-Heinz Krause
Gerhard Merkmann
Werner Schunk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intech Thueringen GmbH
Original Assignee
Intech Thueringen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intech Thueringen GmbH filed Critical Intech Thueringen GmbH
Publication of AU2002213804A1 publication Critical patent/AU2002213804A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a material for producing products (1) having fibrinolytic and/or antibacterial properties. Said material has at least one matrix (2), which is compatible with body tissue and in which a molecular sieve is incorporated. Said molecular sieve is loaded with: at least one active substance (Z) having a fibrinolytic or antibacterial effect; or at least one first active substance (Z1) having a fibrinolytic effect and a second active substance (Z2) having an antibacterial effect. The corresponding molecular sieve/active substance adduct (3) releases the active substance(s) in conjunction with the aqueous body fluid when the matrix (2) is in contact with the body tissue (4). The inventive material is characterized in that the molecular sieve/active substance adduct (3) additionally contains water of crystallization to such an extent that the molecular sieve is partially dehydrated with regard to a sufficient basic molar quantity (m) of water of crystallization. The molecular sieve is loaded with the reduced molar quantity (m') of water of crystallization with the active substance(s) (Z, Z1, Z2) so that an adsorption of water with the desorption of the corresponding active substance occurs when the matrix (2) is in contact with the body tissue (4), whereby the water of crystallization of the molecular sieve increases. The invention also relates to an advantageous method for producing the inventive active substance.
AU2002213804A 2000-10-10 2001-09-19 Material for producing products having fibrinolytic and/or antibacterial properties Abandoned AU2002213804A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10050317.9 2000-10-10
DE10050317 2000-10-10
PCT/DE2001/003587 WO2002030388A2 (en) 2000-10-10 2001-09-19 Material for producing products having fibrinolytic and/or antibacterial properties

Publications (1)

Publication Number Publication Date
AU2002213804A1 true AU2002213804A1 (en) 2002-04-22

Family

ID=7659390

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213804A Abandoned AU2002213804A1 (en) 2000-10-10 2001-09-19 Material for producing products having fibrinolytic and/or antibacterial properties

Country Status (5)

Country Link
EP (1) EP1328306B1 (en)
AT (1) ATE310545T1 (en)
AU (1) AU2002213804A1 (en)
DE (2) DE10146009A1 (en)
WO (1) WO2002030388A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1423153A1 (en) * 2001-09-03 2004-06-02 Intech Thüringen GmbH Medicinal cushion, in particular anti-decubitus cushion
CN113668143B (en) * 2021-08-28 2022-05-27 山东驼王非织造布有限公司 Preparation method of antibacterial polypropylene non-woven fabric

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD294959A5 (en) * 1986-07-14 1991-10-17 Gummiwerke Thueringen Gmbh PROCESS FOR PRODUCING RUBBER ARTICLES WITH FIBRINOLYTIC DEPOT EFFECT
DD264009A1 (en) * 1987-07-17 1989-01-18 Thueringen Gummiwerke Veb NEW MIXTURE OF HIGH-MOLECULAR POLYMER MATERIALS FOR THE MANUFACTURE OF ANTIMYCOTIC PRODUCTS
DD270867B1 (en) * 1988-04-15 1990-08-22 Thueringen Gummiwerke Veb NEW MEANS FOR THE REMOVAL OF TOXIC SUBSTANCES FROM THE BLOOD
DD278492A1 (en) * 1988-12-27 1990-05-09 Jenapharm Veb METHOD FOR PRODUCING AN ANTITHROMBOTIC ACTIVE PAVER
JPH0762242A (en) * 1993-08-27 1995-03-07 Shin Etsu Chem Co Ltd Antimicrobial - mildewproofing silicone rubber composition
JP2889836B2 (en) * 1995-03-16 1999-05-10 鐘紡株式会社 Antibacterial zeolite with little discoloration action and method for producing the same

Also Published As

Publication number Publication date
WO2002030388A2 (en) 2002-04-18
EP1328306B1 (en) 2005-11-23
ATE310545T1 (en) 2005-12-15
WO2002030388A3 (en) 2003-01-09
EP1328306A2 (en) 2003-07-23
DE50108201D1 (en) 2005-12-29
DE10146009A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
MXPA01007710A (en) Freeze-dried agent containing paramylon, production and utilization thereof.
AU4644101A (en) Antiadhesive carbohydrates
AU2525401A (en) Use of an extract of at least one vaccinium-type plant as an anti-glycation agent
CA2321752A1 (en) Solid tcmtb formulations
AU4107300A (en) Polyurethane solutions containing alkoxysilane structural units
EP1228771A4 (en) Use of soluble cellulose derivative having been made hardly soluble in water and process for producing the same
AU8749198A (en) Deodorant and antimicrobial water absorbent, process for the production thereof and absorbent articles
WO1996026747A3 (en) Use of amidoamines in ophthalmic compositions
CA2361402A1 (en) Bis-sulfonamides
EP2017269A3 (en) A pharmaceutical compodition comprising form II crystalline Ritonavir and a preparation thereof
WO2001010408A3 (en) Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
EP1133979A3 (en) Use of specific fatty compounds for modifying the physico-chemical properties of the skin and/or the mucous membrane as agents for preventing or reducing the adhesion of micro-organisms thereon
CA2197544A1 (en) Fungicidal composition comprising metalaxyl and fludioxonil
HK1048446A1 (en) Suture material
CA2379314A1 (en) Tablet for sucking, containing ambroxol
WO1999018420A3 (en) Moisture content indicator system for growing medium
AU2002213804A1 (en) Material for producing products having fibrinolytic and/or antibacterial properties
AU5487101A (en) Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
WO2002058488A3 (en) Composition containing creatine and phosphorus
HK1073228A1 (en) Aromatic herb preparation
CA2331672A1 (en) Dextrin-containing composition for preventing surgical adhesions
WO2003047533A3 (en) Composition for treating the surface of the skin
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
WO2002085325A3 (en) Production and use of a suspension composition comprising an ultrasound contrast medium